Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?19.37
 
WKN: A2PL1Q / Symbol: EDSA / Name: Edesa Biotech / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Edesa Biotech Inc Stock

Our community is currently high on Edesa Biotech Inc with 4 Buy predictions and 0 Sell predictions.
Based on the current price of 0.39 € the target price of 19 € shows a potential of 4809.56% for Edesa Biotech Inc which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Edesa Biotech Inc stock. Criterium "Management" gathered the most positive votes but regarding "Valuation (undervalued/overvalued)" there were negative voices in the community.

Pros and Cons of Edesa Biotech Inc in the next few years

Pros
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Edesa Biotech Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Edesa Biotech Inc - - - - - - -
AEterna Zentaris Inc. 0.610% 0.921% 13.725% -19.180% 12.944% -92.523% -97.902%
StageZero Life Sciences Ltd. 13.210% 12.766% 15.217% -59.848% 17.778% - -
Satellos Bioscience Inc. 4.110% -11.515% -34.234% 2.277% 5.797% -77.188% -

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-30

Upon initial examination, the financials of Edesa Biotech (EDSA) from the Biotechnology & Medical Research industry seem to present a mixed picture. The company is engaged in extensive research and development, which is a positive indication of its focus on innovation. However, several concerning aspects must be carefully considered in terms of its financial health.

Research and Development Expenses: Edesa Biotech has consistently invested in research and development, which is essential for biotechnology companies to discover and develop breakthrough products. From 2020 to 2022, the research and development expenses have consistently increased, indicating a dedication to innovation that may pay off in the long term.

Current Ratio: EDSA maintains a healthy current ratio in recent years, indicating adequate liquidity to meet short-term obligations. In 2021, the current ratio was 8.32, while in 2022 the ratio was 4.25. This suggests financial stability and good cash management in the short term.

Comments

Prediction Buy
Perf. (%) -
Target price 19.606
Change
Ends at 14.02.25

Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
Ratings data for EDSA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 19.133
Change
Ends at 29.11.24

Edesa Biotech, Inc. (NASDAQ: EDSA) had its price target lowered by analysts at HC Wainwright from $70.00 to $21.00. They now have a "buy" rating on the stock.
Ratings data for EDSA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 9.174
Change
Ends at 22.11.24

Edesa Biotech, Inc. (NASDAQ: EDSA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for EDSA provided by MarketBeat
Show more